Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Neurology

Topics

Medicine

Pathology

Physiology

Psychiatry And Mental Health

Pathology And Forensic Medicine

Show all topics

DOI

10.1016/s1474-4422(16)00019-3